75.981             “Pay for Delay” Arrangements by Pharmaceutical Companies

MSSNY will forward a resolution to the American Medical Association exhorting that organization to support the Federal Trade Commission in its efforts to stop these “pay for delay” arrangements.  (HOD 2008-207; Reaffirmed HOD 2018)